Canadian Journal of Gastroenterology and Hepatology / 2017 / Article / Fig 2

Clinical Study

Vonoprazan-Based Regimen Is More Useful than PPI-Based One as a First-Line Helicobacter pylori Eradication: A Randomized Controlled Trial

Figure 2

Comparison of eradication rates between vonoprazan- (VPZ-) based regimen and proton pump inhibitor- (PPI-) based regimen. Intention-to-treat (a) and per-protocol (b) analyses. Statistical analysis was performed by χ2 test. VPZ group, treatment with vonoprazan, amoxicillin, and clarithromycin; PPI group, treatment with rabeprazole or lansoprazole, amoxicillin, and clarithromycin.

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.